Close menu

November 1st, 2022 | 10:59 CET

SAP, Kleos Space, Palantir - Tech stocks about to take off

  • Space
  • Software
  • cloud
Photo credits:

Whether Amazon, Meta Platforms or Alphabet. Third-quarter figures of the technology giants disappointed across the board, and share prices reached new lows for the year. The Walldorf-based software group SAP presented a completely different picture and surprised investors with better-than-expected sales figures. In the next few weeks, it is mainly second-tier technology stocks that could provide positive surprises. Due to the strong correction of the past months, a trend reversal could be heralded in the long term.

time to read: 4 minutes | Author: Stefan Feulner
ISIN: SAP SE O.N. | DE0007164600 , PALANTIR TECHNOLOGIES INC | US69608A1088 , KLEOS SPACE CDI/1/1 | AU0000015588

Table of contents:

    SAP - Cloud business convinces

    Due to the weak euro, Europe's largest software manufacturer is coming through the third quarter better than analysts had forecast. At around EUR 2.1 billion, earnings before interest and taxes adjusted for special effects were on par with the previous year. Sales increased by 15% to EUR 7.84 billion, with two-thirds of the growth coming from currency effects. While software licenses performed weaker than expected, SAP showed a 38% increase in revenue from the cloud, its most important growth area. However, net income slumped 61% to EUR 547 million. Management confirmed its revenue and earnings forecasts for the full year.

    Luka Mucic, CFO of SAP, commented: "We had a strong quarter in cloud and saw increasing momentum in all key cloud metrics. We are at an important inflection point in our realignment and expect accelerated revenue growth and double-digit operating profit growth in 2023." The medium-term objectives for 2025, previously published in its quarterly statement for the third quarter of 2020, were also maintained in the press release. SAP expects to achieve double-digit growth in operating profit in 2023. Given the strong growth momentum in SAP's cloud business and the recent positive development in exchange rates, SAP is expected to update its medium-term targets in the coming quarters.

    Most analysts reacted positively to the better-than-expected figures. US investment bank Goldman Sachs raised its price target from EUR 111 to EUR 121 after the third-quarter figures and reiterated its "buy" investment rating.

    Kleos Space - Ready for take-off

    Current uncertainties in geopolitics and expanding global conflicts are likely to continue to put companies like Luxembourg-based Kleos Space in the spotlight. The Data-as-a-Service company launches clusters of satellites, each consisting of four units, into space to scan the Earth for radio frequency signals for geolocation. The Scouting Mission satellites were launched into a 37-degree inclination, collecting data over crucial areas of interest.

    The data obtained is then processed using in-house algorithms, packaged and sold to government and commercial analysis and intelligence services on a subscription model. To date, 3 satellite clusters have been launched into space, and the fourth cluster, the Observer Mission (KSF3), is now in the starting blocks. Kleos Space confirmed that the satellites will be launched into Sun Synchronous orbit from Cape Canaveral Space Force Station in Florida on SpaceX's Transporter-6 mission, currently scheduled for Q4 2022. Equipped with AIS, VHF and X-band payloads, the four satellites will expand Kleos Space's data collection capacity by up to 119 million sq km per day. This mission also enables Kleos to increase its average daily revisit rate over a 15-degree latitude area of interest to around five times a day.

    The growth company received a prestigious contract from the National Reconnaissance Office (NRO) under the Strategic Commercial Enhancements Broad Agency Announcement. The first-tier contract was awarded based on Kleos' analysis, modeling and simulation of its capabilities to support current and future US government commercial high-frequency reconnaissance needs. Although the Company acknowledged that the financial value of the first-stage contract was immaterial, it believes it has a significant impact on Kleos Space's future potential to serve the US government market.

    Despite the Company's progress, the share price has lost about 67% of its value since the beginning of the year. It is trading at a low for the year of AUD 0.25 on a prominent support line that has been successfully defended several times. Should the Observer Mission launch successfully, Kleos Space's share price could also take off.

    Palantir - Tension ahead of the figures

    After the last quarterly figures, Palantir's share price was characterized by high volatility and heavy losses. It should be exciting on Monday, November 7 before the stock market opens, when the data analysis company, around the headstrong CEO Alex Karp, presents its figures for the third quarter. In the event of a positive surprise, especially in terms of earnings, the scenario could turn around with more substantial price swings in this quarter. The stock has lost about 55% of its value since the beginning of the year but has been able to shine with relative strength in recent weeks. It is close to breaking out of the downtrend at USD 8.95 that has existed since November 2021. A sustained breakout would open up price potential to at least the August high at USD 11.45.

    In any case, new orders continue to run like clockwork. Palantir continues to expand its collaboration with the Food and Drug Administration (FDA), helping the agency modernize its food supply chain and resilience as part of the 21 FORWARD initiative. Palantir will serve as the central operating platform for proactive food supply chain disruption monitoring and crisis response. The contract is valued at USD 22 million.

    The numbers season produced big disappointments, especially for FAANG stocks, but other technology stocks, such as SAP, surprised on the upside. A positive report for Palantir could see a break from the long-term downtrend. Kleos Space should benefit from the approaching Observer Mission.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author

    Related comments:

    Commented by André Will-Laudien on September 14th, 2023 | 09:05 CEST

    Artificial Intelligence in practice? Nvidia, NorCom, Palantir - The next 100% with Big Data

    • AI
    • Software
    • Investments

    The stock market is not a one-way street. Investors are trying to ride the wave of "Artificial Intelligence" (AI), and corresponding stocks such as, Nvidia, Microsoft, or Palantir are performing well in 2023. A new megatrend is underway here, which, according to experts, will continue for several years. However, because of the high valuations in the entire sector, it is worth taking an analytical look. After all, no one knows how long the AI boom will continue to generate decent returns on the stock market. Opportunity-rich stocks still exist in the second and third tier. We are taking a closer look.


    Commented by Juliane Zielonka on August 24th, 2023 | 07:00 CEST

    Defence Therapeutics, Bayer, Palantir - Milestones, Power Shifts and Mishmash

    • Biotechnology
    • Software
    • Technology

    The radiopharmaceuticals market is expected to grow to USD 13.818 billion by 2028. In collaboration with Orano Group, Defence Therapeutics has developed innovative radioactive cancer therapies that destroy cancer at the cellular level, thereby increasing efficacy and minimizing side effects. According to Defence Therapeutics CEO Sebastien Plouffe, this partnership will lead to top-tier therapies in a growing market. Meanwhile, heads are rolling at Bayer, as CEO Bill Anderson has big plans and is replacing key positions with promising candidates. Employees of the British NHS have probably spoken a bit too much. The US company Palantir has been awarded five NHS contracts without competitive bidding and is currently the favorite for a multi-million dollar contract in the healthcare sector. Find out what this means for investors here.


    Commented by Stefan Feulner on August 10th, 2023 | 08:30 CEST

    Palantir, First Phosphate, E.ON - A decade of growth

    • Mining
    • phosphate
    • Utilities
    • Software

    The climate transition requires significant investments in energy infrastructure, which should benefit companies like the utility provider E.ON well beyond the current decade. Another beneficiary of this transformation are producers of the raw materials needed for the energy transition, for which demand already exceeds scarce supply in some areas.